Full Episode
Friday, Nov 28
PBS NewsHour
  • Episodes
  • Podcasts
  • Newsletters
  • The Latest
  • Politics
    Politics
    • Brooks and Capehart
    • Politics Monday
    • Supreme Court
  • Arts
    Arts
    • CANVAS
    • Poetry
    • Now Read This
  • Nation
    Nation
    • Supreme Court
    • Race Matters
    • Essays
    • Brief But Spectacular
  • World
    World
    • Agents for Change
  • Economy
    Economy
    • Making Sen$e
    • Paul Solman
  • Science
    Science
    • The Leading Edge
    • ScienceScope
    • Basic Research
    • Innovation and Invention
  • Health
    Health
    • Long-Term Care
  • Education
    Education
    • Teachers' Lounge
    • Student Reporting Labs
  • For Teachers
    Education
    • Newshour Classroom
  • About
    • Feedback
    • Funders
    • Support
    • Jobs

Support PBS News: Make triple the impact this Giving Tuesday

We need 1,500 new monthly donors this Giving Tuesday.

Give Monthly

Every new monthly gift will be matched 3X until midnight, December 2.

PBS News

Get news alerts from PBS News

Turn on desktop notifications?

alzheimer's disease

  • Full Episodes
  • Podcasts
  • Newsletters
  • Live
Alzheimer's patients are cared for in Bartlett

Health Nov 15

Why one man with a genetic predisposition for Alzheimer’s disease is defying the odds

By Ali Rogin, Andrew Corkery

Science Aug 28

New hope for Alzheimer's: Groundbreaking Harvard study finds lithium reverses brain aging
4 things to know about a new study on lithium and Alzheimer’s disease

A recent study from Harvard Medical School asks whether the element lithium might be a key factor in whether someone develops Alzheimer’s disease.

By Genesis Magpayo

Health Jul 30

Terez Redai, 88, talks with Margareta nursing home employees after using VR goggles, in Kecskemet
Watch 6:34
Study reveals simple lifestyle changes could help prevent dementia

An estimated 42% of Americans over 55 will eventually develop dementia. A new study revealed the strongest evidence yet that a balanced diet, consistent exercise and social activity helped improve cognition. Amna Nawaz discussed the study with Jessica Langbaum, the…

By Amna Nawaz, Courtney Norris

Health Jul 28

A scientist looks at hypometabolic and hypoperfusion patterns at the single-subject level from a patient suffering from Al...
Blood tests for Alzheimer’s may be coming to your doctor’s office. Here are 4 things to know

New blood tests could help doctors diagnose Alzheimer’s disease faster and more accurately, researchers reported Sunday – but some appear to work far better than others.

By Lauren Neergaard

Health Jul 02

FILE PHOTO: Eli Lilly logo is shown on one of their offices in San Diego
FDA approves 2nd Alzheimer’s drug that can modestly slow dementia

Kisunla is not a cure and slows worsening memory and cognitive problems by about seven months.

By Matthew Perrone, Associated Press

Jun 10

FDA advisers back Alzheimer’s drug that can slow disease

By Matthew Perrone, Associated Press

If the agency agrees with the panel's recommendation, the drug, donanemab, would only be the second Alzheimer’s drug cleared in the U.S. shown to convincingly slow cognitive decline and memory problems due to Alzheimer's.

Continue reading

May 06

New research shows people carrying 2 copies of a certain gene are more likely to have Alzheimer’s

By Lauran Neergaard, Associated Press

For the first time, researchers have identified a genetic form of late-in-life Alzheimer's disease. A gene called APOE4 has long been considered a key risk factor. But new research says if people inherit two copies of that gene it's not…

Continue reading

Oct 26

Watch 5:32
Artist turns her work into love letters to husband fading into the fog of Alzheimer’s

By Pamela Watts, Dorothy Dickie

We bring you a story about art and love involving a Massachusetts artist whose work took a dramatic turn when her husband began to lose himself to Alzheimer’s disease. Rhode Island PBS Weekly reporter Pamela Watts reports for our arts…

Continue watching

Aug 11

Insurers view new Alzheimer’s drug as experimental, won’t cover treatment for some customers

By Tom Murphy, Associated Press

Some private insurers are balking at paying for the first drug fully approved to slow mental decline in Alzheimer’s patients.

Continue reading

Jul 06

Alzheimer’s drug Leqembi has full FDA approval, clearing way for Medicare coverage

By Matthew Perrone, Associated Press

The FDA gave it conditional approval in January based on early results suggesting the drug could modestly slow cognitive decline.

Continue reading

Jump to the First Page Previous Page
1 2 3 4 5
Next Page Jump to the Last Page

Support Provided By: Learn more

gt-sidebar

Educate your inbox

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

Form error message goes here.

Thank you. Please check your inbox to confirm.

Full Episode
Friday, Nov 28
  • BDO
  • BNSF Railway
  • Consumer Cellular
  • Raymond James
  • Viewers Like You
  • Friends of the News Hour
PBS News

© 1996 - 2025 NewsHour Productions LLC. All Rights Reserved.

PBS is a 501(c)(3) not-for-profit organization.

Sections

  • The Latest
  • Politics
  • Arts
  • Nation
  • World
  • Economy
  • Science
  • Health
  • Education

About

  • About Us
  • TV Schedule
  • Press
  • Feedback
  • Funders
  • Support
  • Newsletters
  • Podcasts
  • Jobs
  • Privacy
  • Terms of Use

Stay Connected

  • Facebook
  • YouTube
  • Instagram
  • X
  • TikTok
  • Threads
  • RSS

Subscribe to Here's the Deal with Lisa Desjardins

Form error message goes here.

Thank you. Please check your inbox to confirm.

Support our journalism

Support for News Hour Provided By

  • BDO
  • BNSF Railway
  • Consumer Cellular
  • Raymond James
  • Viewers Like You